Phase II trial of the cannabinoid compounds, GWP 42003 and GWP 42004, in patients with metabolic disorders.

Trial Profile

Phase II trial of the cannabinoid compounds, GWP 42003 and GWP 42004, in patients with metabolic disorders.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 01 Oct 2012

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top